PHILADELPHIA, Nov. 30, 2016 /PRNewswire/ -- ACI Clinical, the
leading independent specialty provider of Endpoint Adjudication and
Data Monitoring Committees to the clinical trial industry, is proud
to announce the addition of two new executives, Andrew MacKnight and Amit Bhattacharyya. Both are seasoned industry
professionals with successful track records managing organizational
growth.
"Timing is perfect to welcome Andrew and Amit into the company
as we are continuing to build more and more pharma, biotech and
device client partnerships to support global expert committee
operations," says Amy Ghelardi,
Director of Client Services. "Andrew and Amit have a great deal of
management experience and I am confident that their operational
expertise and leadership will benefit our clients looking to
outsource the setup and management of their committees to ACI for a
fully integrated, standardized approach that can easily be applied
study to study."
Andrew MacKnight joined ACI
Clinical as Vice President of Operations with a background in
strategic product development and business management in the Life
Sciences industry. His experience in the CRO sector includes
leadership of commercial operations at Covance, and responsibility
for acquisitions and integration at inVentiv Health Clinical. He
also spent over 12 years at GlaxoSmithKline in strategic product
development roles with an emphasis on global vaccines and public
health.
Amit Bhattacharyya joined ACI
Clinical as Vice President of Biometrics to lead the Statistics and
Programming functions, bringing 23 years of his GSK experience in
the applied statistics and programming fields. At GSK, he served in
technical, leadership and global management roles while supporting
R&D studies in Preclinical Discovery, Clinical Development and
Health Outcomes disciplines. He brings rich experiences from
working globally in the UK, India
and US, and from his involvement in various statistical societies
over the years.
ACI Clinical president, Dr. Jonathan
Seltzer, commented: "We're thrilled to add Andrew and Amit
to our team. Their decades of leadership experience at major
companies enhances our scalability and expertise."
About ACI Clinical
ACI Clinical is a niche provider of
clinical trial committees and clinical trial advisory services. The
company offers the largest committee dedicated staff in the
industry, its own global network of more than 500 experienced
clinicians, and proprietary technologies designed specifically to
enable streamlined committee processes. Company executives maintain
involvement in public-private thought leadership efforts to improve
the quality and effectiveness of clinical trials, and currently
participate in projects with the Cardiac Safety Research Consortium
(CSRC), the Clinical Trials Transformation Initiative (CTTI), the
Clinical Data Interchange Standards Consortium (CDISC), and the
American Statistical Association (ASA).
Contact Information
Phone: +1 484-429-7200
Email: info@aciclinical.com
Logo -
http://photos.prnewswire.com/prnh/20131120/PH19940LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aci-clinical-expands-leadership-team-to-support-growth-300369911.html
SOURCE ACI Clinical